[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
October 16, 1915

American Salvarsan

Author Affiliations


JAMA. 1915;LXV(16):1387-1388. doi:10.1001/jama.1915.02580160071030

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


To the Editor:  —It may interest you to know that, in the course of chemotherapeutic researches which Dr. Raiziss, Dr. Kolmer and myself have carried out in the Dermatological Research Department of the Philadelphia Polyclinic during the past year or more, we have reproduced salvarsan and have made a number of new arseno-benzol products. We have given over 100 injections of our salvarsan to hospital patients with excellent therapeutic results and with no untoward effects.I understand that the supply of salvarsan in this country is exhausted and that the American agents do not know when the drug can be imported from Germany. The American patents are held in the name of Ehrlich and Bertheim, but have doubtless been consigned to the manufacturing company of Lucius and Brüning of Frankfort, Germany.As salvarsan is necessary to save life as well as to prevent the spread of syphilis, it is eminently

First Page Preview View Large
First page PDF preview
First page PDF preview